Methotrexate for Central Serous Chorioretinopathy Treatment Trial

Clinical trial NCT01633983 · UNKNOWN

Trial details

NCT number: NCT01633983
Sponsor: Edward Averbukh
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Central Serous Chorioretinopathy

Start date: 2012-08-01
Primary completion: 2014-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.